The Alfresa Group is committed to working to address the eight Important Sustainability Issues that were identified in accordance with the Group's principles and Basic Sustainability Policy. The 22-24Mid-term Management Plan, which goes through the fiscal year ending March 31, 2025, and the Alfresa Group's Medium- to Long-Term Vision, which continues to the fiscal year ending March 31, 2033, are milestones along the path to the Group's goal of becoming a "Healthcare
The Alfresa Group's Basic Sustainability Policy
Consortium that provides products and services in every health-related field."
The Alfresa Group's Principles
Our Philosophy
We create and deliver a fresh life for all.
The Alfresa
The Alfresa
The Alfresa
Group's
Group's Human
Group's
Environmental
Rights Policy
Diversity Policy
Policy
Corporate
The Alfresa
Group
Governance
Compliance
Guidelines
Guidelines
Important Sustainability Issues
Improvement of quality of products and services
Value creation and innovation
Environmental protection
Contribution to local communities
Active participation of human resources
Compliance
Risk management
Corporate governance
Our Vision
We aim to become a Healthcare Consortium that provides products and
services in every health-related field.
Our Promises
Reliability Safety Sincerity
We always provide reliable products and services and strive to enhance customer satisfaction.
We respect individual characteristics and personalities and strive to maintain and improve a pleasant working environment.
We raise corporate value as a corporate group operating in the health-related industry.
We conduct proper trade under fair and free competition.
We strive to proactively engage with society by providing appropriate information in a timely manner.
We contribute to local communities through our business operations.
We strive to protect the global environment.
Note: Healthcare Consortium is a registered trademark owned by the Alfresa Group in Japan.
The Alfresa Group's Aspiration (Long-Term Goals)
Become a Healthcare Consortium that provides products and
services in every health-related field
Medium- to Long- Term Vision
Improve corporate value over the medium to long term by becoming a Healthcare
Consortium and improving capital efficiency through balance sheet controls
22-24Mid-term Management Plan
Leap into the Future
"An Evolving Healthcare Consortium"
1.Enhancement of business models and creation of new value
2.Contribution to local health and treatments through united Group efforts
3.Contribution toward a sustainable society through initiatives to protect the environment
4.Promotion of a human resource strategy focused on diversity
5.Cultivation of a corporate culture with compliance as its highest priority
2
Alfresa Group Integrated Report 2023
Alfresa Group Integrated Report 2023
3
Attachments
Original Link
Original Document
Permalink
Disclaimer
Alfresa Holdings Corporation published this content on 24 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 October 2023 08:19:35 UTC.
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
ALFRESA HOLDINGS CORPORATION 
